Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Tadalafil/TU:

Search results

Items: 1 to 20 of 183

1.

Possible Drug-nutraceutical Interaction leading to Unexpected Sequelae after Inguinal Hernia Repair.

Smith MR, Faingold C, Mellinger JD.

Am J Case Rep. 2018 Jul 17;19:836-838. doi: 10.12659/AJCR.908117.

2.

Interval importance index to select relevant ATR-FTIR wavenumber Intervals for falsified drug classification.

Kahmann A, Anzanello MJ, Fogliatto FS, Chaovalitwongse WA, Marcelo MCA, Ferrão MF, Ortiz RS, Mariotti KC.

J Pharm Biomed Anal. 2018 Sep 5;158:494-503. doi: 10.1016/j.jpba.2018.06.046. Epub 2018 Jun 25.

PMID:
29966946
3.

Effect of co-administration of two different phosphodiesterase inhibitors and a β3-adrenoceptor agonist in an experimental model of detrusor overactivity.

Linhares BL, Nascimento NRF, Gonzaga-Silva LF, Santos CF, Moraes MO, Marinho LB, Silva APG, Fonteles MC, Reges R.

Eur J Pharmacol. 2018 Aug 15;833:425-431. doi: 10.1016/j.ejphar.2018.06.018. Epub 2018 Jun 18.

PMID:
29913125
4.

[The role of tadalafil in the management of sexual dysfunctions].

Efremov EA, Kasatonova EV, Mel'nik YI, Nikushina AA.

Urologiia. 2018 May;(2):108-113. Russian.

PMID:
29901304
5.

Daily tadalafil for the chronic phase of stuttering priapism: a case report.

Massenio P, D'Altilia N, Sanguedolce F, Carrieri G, Cormio L.

BMC Urol. 2018 May 31;18(1):54. doi: 10.1186/s12894-018-0368-x.

6.

Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction.

Bolat MS, Cinar O, Akdeniz E, Aşcı R.

Int J Impot Res. 2018 Jun;30(3):102-107. doi: 10.1038/s41443-018-0019-5. Epub 2018 May 25.

PMID:
29795527
7.

[Effects of different medications with tadalafil on erectile dysfunction in males with primary sexual failure].

Li WJ, Xu MX, Guo JH, Cai ZK, Jiang YQ, Wang Z.

Zhonghua Nan Ke Xue. 2017 Jun;23(6):522-526. Chinese.

PMID:
29722944
8.

Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet.

Park SI, Heo SH, Kim G, Chang S, Song KH, Kim MG, Jin EH, Kim J, Lee S, Hong JH.

Drug Des Devel Ther. 2018 Apr 20;12:935-942. doi: 10.2147/DDDT.S155040. eCollection 2018.

9.
10.

Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction.

Furuta A, Suzuki Y, Igarashi T, Koike Y, Egawa S, Yoshimura N.

Int Urol Nephrol. 2018 May;50(5):839-844. doi: 10.1007/s11255-018-1835-8. Epub 2018 Mar 8.

PMID:
29520560
11.

Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.

Mulhall JP, Hassan TA, Rienow J.

Int J Clin Pract. 2018 Apr;72(4):e13074. doi: 10.1111/ijcp.13074. Epub 2018 Feb 20.

PMID:
29460994
12.

Effect of Tadalafil on Seizure Threshold and Activity of Antiepileptic Drugs in Three Acute Seizure Tests in Mice.

Socała K, Nieoczym D, Pieróg M, Wyska E, Szafarz M, Doboszewska U, Wlaź P.

Neurotox Res. 2018 Oct;34(3):333-346. doi: 10.1007/s12640-018-9876-4. Epub 2018 Feb 9.

13.

Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.

Deibert P, Lazaro A, Stankovic Z, Schaffner D, Rössle M, Kreisel W.

World J Gastroenterol. 2018 Jan 21;24(3):438-444. doi: 10.3748/wjg.v24.i3.438.

14.
15.

Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis.

Wang Y, Bao Y, Liu J, Duan L, Cui Y.

Low Urin Tract Symptoms. 2018 Jan;10(1):84-92. doi: 10.1111/luts.12144. Epub 2016 Nov 5. Review.

PMID:
29341503
16.

Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).

Takahashi R, Miyazato M, Nishii H, Sumino Y, Takayama K, Onzuka M, Oshiro T, Saito S, Fujimoto N, Mimata H, Eto M.

Low Urin Tract Symptoms. 2018 Jan;10(1):76-83. doi: 10.1111/luts.12143. Epub 2016 Nov 5.

PMID:
29341501
17.

Pulmonary Hypertension and Its Response to Treatment in a Patient with Kyphosis-related Alveolar Hypoventilation.

Okada S, Sugawara A, Yamagata S, Takeuchi S, Watanuki Z.

Intern Med. 2018 Apr 1;57(7):1003-1006. doi: 10.2169/internalmedicine.9244-17. Epub 2017 Dec 21.

18.

Tadalafil protector effect during ischemia-reperfusion in rats.

Wietzikoski EGG, Foiatto JC, Czeczko NG, Malafaia O, Koleski FC, Mierzwa TC, Gomes RPX.

Acta Cir Bras. 2017 Nov;32(11):973-983. doi: 10.1590/s0102-865020170110000009.

19.

Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in guinea pigs.

Urbanova A, Medvedova I, Kertys M, Mikolka P, Kosutova P, Mokra D, Mokrý J.

Exp Lung Res. 2017 Nov - Dec;43(9-10):407-416. doi: 10.1080/01902148.2017.1386735. Epub 2017 Dec 8.

PMID:
29220595
20.

Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study).

D'Alto M, Romeo E, Argiento P, Paciocco G, Prediletto R, Ghio S, Correale M, Lo Giudice F, Badagliacca R, Greco A, Vizza CD.

J Cardiovasc Med (Hagerstown). 2018 Jan;19(1):12-17. doi: 10.2459/JCM.0000000000000590.

PMID:
29215546

Supplemental Content

Loading ...
Support Center